Hypotheses

Replacing 50% of astrocytes, the support cells in each suprachiasmatic nucleus of the hypothalamus, once would preserve function across five domains and extend survival through year 20. The claim requires benefits despite continued aging elsewhere; improved clock markers alone would not establish it.

Explains the gap: Which anatomical structures and cellular compartments constitute a sufficient replacement set when randomized omissions, rival combinations, and equivalent-care controls must distinguish necessity from compensation across all five functional domains and survival over 20 years?

The proposed human set combines distributed organizer cells with regenerated liver, muscle, blood-forming and thymic tissue after one treatment. It predicts that graft location determines functional renewal: distributed grafts qualify while clustered grafts with comparable survival and regenerated mass fail.

Explains the gap: Which anatomical structures and cellular compartments constitute a sufficient replacement set when randomized omissions, rival combinations, and equivalent-care controls must distinguish necessity from compensation across all five functional domains and survival over 20 years?

In the age-60 starting population under otherwise equivalent care, no tissue replacement set meets the required benefits across all five domains and both survival outcomes. A single reproducibly qualifying set would falsify this claim, even if its minimum size remained unknown.

Explains the gap: Which anatomical structures and cellular compartments constitute a sufficient replacement set when randomized omissions, rival combinations, and equivalent-care controls must distinguish necessity from compensation across all five functional domains and survival over 20 years?

Replacing 50% of the age-60 blood stem-cell pool and 50% of each thymic lining-cell compartment would prevent wider decline. The combined set must qualify where partial sets fail; a diverse graft must preserve infection clearance and independence longer than a graft dominated by a few clones.

Explains the gap: Which anatomical structures and cellular compartments constitute a sufficient replacement set when randomized omissions, rival combinations, and equivalent-care controls must distinguish necessity from compensation across all five functional domains and survival over 20 years?

Replacing 20% of age-60 gluteofemoral fat and complete motor units, with associated tendon replacement, would preserve recovery after illness or inactivity. The combined set must meet the full clinical outcome pattern; isolated strength or insulin-sensitivity gains reject it.

Explains the gap: Which anatomical structures and cellular compartments constitute a sufficient replacement set when randomized omissions, rival combinations, and equivalent-care controls must distinguish necessity from compensation across all five functional domains and survival over 20 years?

The hypothesis claims that replacing 10% of age-60 skeletal-muscle myonuclei, the nuclei within muscle fibers, across all major regions once preserves all five clinical domains through year 20. Failure at lower fractions and with the same introduced mass confined to a few muscles would distinguish the claim.

Explains the gap: How many cumulative grams per person and what percentages of each named functional unit remain necessary after experimental fraction and schedule reduction, counting growth and repeats over 20 years, and where do these minima conflict?

The hypothesis proposes replacing 20% of kidney, liver and left-ventricular functional units in one initial course, with no repeat before year 20. All three compartments provide recovery reserve; a qualifying omission, lower fraction or durable single-compartment strategy would disprove the minimum.

Explains the gap: How many cumulative grams per person and what percentages of each named functional unit remain necessary after experimental fraction and schedule reduction, counting growth and repeats over 20 years, and where do these minima conflict?

In the specified starting population, no tissue set of any size meets the complete required benefit criterion once all assigned recipients and treatment harms are counted. Any reproducibly qualifying nonzero replacement strategy would disprove the claim.

Explains the gap: How many cumulative grams per person and what percentages of each named functional unit remain necessary after experimental fraction and schedule reduction, counting growth and repeats over 20 years, and where do these minima conflict?

The hypothesis proposes replacing complete fat-tissue units in abdominal and gluteofemoral subcutaneous depots, then repeating replacement at year 10. Protection through year 20 would require both depots and renewal, with benefit tracking reduced ectopic lipid accumulation and exposure.

Explains the gap: How many cumulative grams per person and what percentages of each named functional unit remain necessary after experimental fraction and schedule reduction, counting growth and repeats over 20 years, and where do these minima conflict?

Replacing 90% of myeloid-biased long-term hematopoietic stem cells—blood-forming cells biased toward myeloid output—with balanced-output cells is proposed to suffice through year 20. Stable balanced donor–host output without multidomain and survival benefit would falsify the claim.

Explains the gap: How many cumulative grams per person and what percentages of each named functional unit remain necessary after experimental fraction and schedule reduction, counting growth and repeats over 20 years, and where do these minima conflict?

In aged animals with reduced-fraction renal replacements, suppressing the graft’s daily clock would rescue fluid regulation and cognition without adding tissue. Suppression must outperform optimal clock alignment during randomized exposure shifts, with benefit reversing when oscillation returns.

Explains the gap: Can physiological phase realignment rescue a failing reduced-fraction replacement without adding tissue, and does the Nyquist stability criterion predict when ordinary meal, posture, and activity shifts reverse that rescue?

In replacement-derived kidney tubular cells, sustained alignment of host hormonal signals could lock in mature function without adding tissue. Persistent recovery after the original schedule resumes, with a lasting cell-state change and unchanged cell number and mass, would distinguish this claim.

Explains the gap: Can physiological phase realignment rescue a failing reduced-fraction replacement without adding tissue, and does the Nyquist stability criterion predict when ordinary meal, posture, and activity shifts reverse that rescue?

In aged animals, the hypothesis predicts that timing changes reduce brain exposure to circulating neuroactive compounds. Changing the responsible transporter would abolish or reproduce cognitive rescue without changing heart–kidney dynamics.

Explains the gap: Can physiological phase realignment rescue a failing reduced-fraction replacement without adding tissue, and does the Nyquist stability criterion predict when ordinary meal, posture, and activity shifts reverse that rescue?

In aged animals bearing grafts—transplanted tissue—learned sensory cues could restore function at a fixed tissue fraction. Recovery at a novel clock time, loss of benefit when the association fades, and return after relearning would distinguish cue memory from biological timing.

Explains the gap: Can physiological phase realignment rescue a failing reduced-fraction replacement without adding tissue, and does the Nyquist stability criterion predict when ordinary meal, posture, and activity shifts reverse that rescue?

Timing alignment does not reproducibly rescue reduced-fraction tissue replacement under equivalent exposure. Comparisons that control testing and selection biases would show no clinically meaningful fluid-recovery or cognition benefit, and independently fitted stability models would fail held-out prediction.

Explains the gap: Can physiological phase realignment rescue a failing reduced-fraction replacement without adding tissue, and does the Nyquist stability criterion predict when ordinary meal, posture, and activity shifts reverse that rescue?

In aged graft-bearing mice, treatment order is proposed to create a brain memory that sustains infection and poor physical recovery. Inhibiting the tagged nerve cells should restore pathogen clearance and physical performance; reactivating them should restore susceptibility.

Explains the gap: Does stronger graft protection or faster normalization of insulin sensitivity prolong infection recovery, and can a staged immune-metabolic regimen preserve graft function while preventing subsequent physical decline?

The hypothesis says graft-reactive and pathogen-reactive T cells compete for contact with antigen-presenting cells. An initial mouse test separates presentation while matching other conditions; persistence of the treatment-order benefit would reject this competition as the dominant explanation.

Explains the gap: Does stronger graft protection or faster normalization of insulin sensitivity prolong infection recovery, and can a staged immune-metabolic regimen preserve graft function while preventing subsequent physical decline?

The apparent trade-off combines distinct causes of poor recovery and selection of survivors. A randomized comparison of immune regimens and metabolic timing would refute this claim if their interaction reproducibly altered viable-pathogen clearance and physical recovery assessed with deaths included.

Explains the gap: Does stronger graft protection or faster normalization of insulin sensitivity prolong infection recovery, and can a staged immune-metabolic regimen preserve graft function while preventing subsequent physical decline?

In graft-derived epithelial cultures, drug order changes infectious viral yield even without immune or neural cells. Disrupting the implicated interaction controlling viral-protein degradation would abolish this effect, supporting a mechanism inside infected graft cells.

Explains the gap: Does stronger graft protection or faster normalization of insulin sensitivity prolong infection recovery, and can a staged immune-metabolic regimen preserve graft function while preventing subsequent physical decline?

Persistent platelet-fibrin blockages could delay insulin delivery and immune-cell access in skeletal muscle. Reopening capillaries should restore delivery and muscle performance; restoring insulin signaling without reopening them should fail.

Explains the gap: Does stronger graft protection or faster normalization of insulin sensitivity prolong infection recovery, and can a staged immune-metabolic regimen preserve graft function while preventing subsequent physical decline?

In aged animals, the hypothesis predicts that greater restored cardiac reserve—the heart’s extra pumping capacity—causes more small-vessel injury and fewer independent-function-equivalent days. Reducing transmitted pressure pulses while preserving reserve would rescue outcomes; verified benefit or neutrality would refute it.

Explains the gap: If replacement durably restores the predicted limiting reserve, yet fails to slow decline in all five domains or extend independent survival, does that falsify the bottleneck-replacement framework despite successful engraftment?

In aged-animal graft experiments, harmful gut microbes could erase the benefit of restored reserve. Giving the same protective microbial community before versus after harmful microbes take hold tests whether arrival order determines clinical benefit despite matched reserve and treatment exposure.

Explains the gap: If replacement durably restores the predicted limiting reserve, yet fails to slow decline in all five domains or extend independent survival, does that falsify the bottleneck-replacement framework despite successful engraftment?

In aged animals, replacement may restore reserve—the capacity to meet added demand—without slowing aging across the body. A precise randomized comparison would distinguish local improvement from broader benefit; reproducible benefit after removing a competing treatment harm would refute the claim.

Explains the gap: If replacement durably restores the predicted limiting reserve, yet fails to slow decline in all five domains or extend independent survival, does that falsify the bottleneck-replacement framework despite successful engraftment?

In aged-animal graft comparisons, blood-contact injury could cancel the benefit of restored reserve. A preparation that reduces clotting should reduce later functional decline; preventing this clotting without recovering clinical benefit would refute it as the dominant cause.

Explains the gap: If replacement durably restores the predicted limiting reserve, yet fails to slow decline in all five domains or extend independent survival, does that falsify the bottleneck-replacement framework despite successful engraftment?

For replacement strategies requiring preparation that damages DNA, lasting mutations in retained blood-forming and epithelial stem cells could offset restored reserve. Matched graft success with fewer new mutations, less delayed disease and better functional survival after non-damaging preparation would support this claim.

Explains the gap: If replacement durably restores the predicted limiting reserve, yet fails to slow decline in all five domains or extend independent survival, does that falsify the bottleneck-replacement framework despite successful engraftment?

The hypothesis claims that starting to stand and walk together erases recently formed memories. Selective loss of items learned before the transition on later recognition testing while stationary would distinguish erasure from poor immediate responses.

Explains the gap: Can combined walking and posture transitions reproducibly impair cognition despite adequate isolated organ reserves, and can changing transition timing prevent impairment without reducing total activity?

Walking initiation, postural cardiovascular compensation, and cerebrovascular adjustment use mismatched timing estimates. A model fitted to one session predicts which preparatory cue lead time minimizes cerebral-flow deficits and cognitive errors in held-out sessions.

Explains the gap: Can combined walking and posture transitions reproducibly impair cognition despite adequate isolated organ reserves, and can changing transition timing prevent impairment without reducing total activity?

Simultaneous standing and walking may briefly obstruct blood draining from the brain despite adequate arterial and organ reserve. Preserving neck venous drainage at identical transition timing and work would prevent impairment; rescue without a drainage change would argue against the mechanism.

Explains the gap: Can combined walking and posture transitions reproducibly impair cognition despite adequate isolated organ reserves, and can changing transition timing prevent impairment without reducing total activity?

In recipients with recruitable right-to-left shunts—routes that can open and let blood bypass lung filtration—coincident standing, bracing, and initial strides allow particles to reach brain vessels. Particle signals preceding cognitive errors, and disappearing with separated transitions, would distinguish this claim.

Explains the gap: Can combined walking and posture transitions reproducibly impair cognition despite adequate isolated organ reserves, and can changing transition timing prevent impairment without reducing total activity?

During walking and posture changes, testing conditions create apparent cognitive impairment. With the same walking dose, verified stimulus delivery and delayed stationary recognition should remove the timing effect; persistent delayed deficits across testing modes would falsify this account.

Explains the gap: Can combined walking and posture transitions reproducibly impair cognition despite adequate isolated organ reserves, and can changing transition timing prevent impairment without reducing total activity?

Replacement-derived muscle may release glucose during recovery and cause most excess glucose appearance during rebounds. Labelled glucose export from isolated muscle and loss of rebounds after muscle-specific G6PC3 suppression would distinguish this account.

Explains the gap: Does restored muscle glucose uptake destabilize meal–activity control by increasing feedback gain, and can phase realignment restore damping without changing tissue quantity, calories, or activity?

Growing swings in circulating glucose are a timing artifact: continuous glucose monitoring (CGM) and blood samples are misaligned. A shared clock and frequent reference blood measurements would show diminishing responses under both meal–activity schedules; reproducible growth in blood would refute the claim.

Explains the gap: Does restored muscle glucose uptake destabilize meal–activity control by increasing feedback gain, and can phase realignment restore damping without changing tissue quantity, calories, or activity?

Replacement muscle may hold enough glycogen, its stored carbohydrate fuel, in the wrong places for active muscle fibres to use. Moving that fuel between compartments must change when blood-glucose extraction rises abruptly, even when total glycogen stays constant.

Explains the gap: Does restored muscle glucose uptake destabilize meal–activity control by increasing feedback gain, and can phase realignment restore damping without changing tissue quantity, calories, or activity?

In recipients using injected insulin, activity releases insulin remaining under the skin. A rise in injected insulin without a matching C-peptide secretion pulse, plus excursions that change with injection location, would distinguish this explanation.

Explains the gap: Does restored muscle glucose uptake destabilize meal–activity control by increasing feedback gain, and can phase realignment restore damping without changing tissue quantity, calories, or activity?

Restored muscle may overwhelm the retained liver's energy supply for recycling lactate into glucose during activity and recovery. The claim fails if liver energy status stays preserved and glucose production remains below its limit throughout symptomatic episodes.

Explains the gap: Does restored muscle glucose uptake destabilize meal–activity control by increasing feedback gain, and can phase realignment restore damping without changing tissue quantity, calories, or activity?

In a post-heat animal preparation, independently controlled arterial supply tests whether raised kidney vein pressure temporarily supports filtration. Lower filtration after pressure release, reversed by restoring modest pressure without cerebral deterioration, would support the claim.

Explains the gap: Does successful fluid conservation during heat create the subsequent renal deficit through venous congestion, and can staged rehydration prevent that reversal while preserving cerebral perfusion?

In renal epithelial tissue after heat, abrupt salt-water restoration may exhaust adenosine triphosphate (ATP), reducing filtration. At matched fluid balance, pressures and arterial supply without crystallization, lower-dissipation recovery should preserve ATP and filtration; equal recovery would reject the explanation.

Explains the gap: Does successful fluid conservation during heat create the subsequent renal deficit through venous congestion, and can staged rehydration prevent that reversal while preserving cerebral perfusion?

In the specified mild heat–activity setting, rehydration schedules change estimated kidney filtration without changing actual clearance or recovery. Equivalent serial clearance of an externally supplied marker supports this claim; a reproducible decline beyond measurement uncertainty falsifies it.

Explains the gap: Does successful fluid conservation during heat create the subsequent renal deficit through venous congestion, and can staged rehydration prevent that reversal while preserving cerebral perfusion?

The hypothesis proposes that uric-acid microcrystals obstruct kidney tubules after circulating volume recovers. In a renal preparation with matched pressure, fluid volume, sodium exposure, and oxygen supply, preventing or dissolving those crystals would restore filtration.

Explains the gap: Does successful fluid conservation during heat create the subsequent renal deficit through venous congestion, and can staged rehydration prevent that reversal while preserving cerebral perfusion?

During supervised oral rehydration, retained fluid may remain in the gut rather than restore circulation. The hypothesis predicts that kidney filtration and brain recovery track water entering circulation; matching that entry across drinking schedules should eliminate their renal difference.

Explains the gap: Does successful fluid conservation during heat create the subsequent renal deficit through venous congestion, and can staged rehydration prevent that reversal while preserving cerebral perfusion?

In infected engineered human muscle coupled to an immune-cell culture, muscle-derived defence peptides could help clear bacteria. Removing their sequences should impair clearance; adding the peptides back should restore it without restoring force or changing oxygen and nutrient availability.

Explains the gap: During infection, does preserving restored locomotor output prolong illness by defeating protective demand shedding, or does downshifting instead cause persistent neural-contractile loss that erases its benefit?

The hypothesis predicts that activity delays pathogen clearance more when metabolic reserve is depleted than after replenishment, even at the same total load. Selectively restoring available substrate should shift when activity becomes tolerable; no shift would reject the mechanism.

Explains the gap: During infection, does preserving restored locomotor output prolong illness by defeating protective demand shedding, or does downshifting instead cause persistent neural-contractile loss that erases its benefit?

In clinically mild infection, brief activity reduction causes no lasting functional loss, and safe movement causes no meaningful clearance delay. Randomized policy differences within prespecified clinical equivalence margins would support this claim; reproducible differences exceeding them would falsify it.

Explains the gap: During infection, does preserving restored locomotor output prolong illness by defeating protective demand shedding, or does downshifting instead cause persistent neural-contractile loss that erases its benefit?

In paired engineered-muscle preparations, the hypothesis predicts that stretch during infection-related oxidation leaves lasting changes in titin, a muscle spring protein. Comparing loading at different muscle lengths and reversing the changes outside the body would test whether they explain altered elasticity.

Explains the gap: During infection, does preserving restored locomotor output prolong illness by defeating protective demand shedding, or does downshifting instead cause persistent neural-contractile loss that erases its benefit?

In recipients receiving tacrolimus, a drug that suppresses immune activity, active drug exposure would explain delayed infection clearance and impaired function. Outcomes tracking unbound drug, and improvement after exposure correction without changing activity policy, would distinguish this explanation.

Explains the gap: During infection, does preserving restored locomotor output prolong illness by defeating protective demand shedding, or does downshifting instead cause persistent neural-contractile loss that erases its benefit?

After stressful tissue replacement or illness, learned cues could restrict regional blood flow despite intact capacity. Matched-workload challenges would test whether counterconditioning removes blood-flow and cognitive deficits and cue reinstatement restores them within minutes.

Explains the gap: Does apparent recovery conceal persistent microvascular reserve loss that makes repeat output gains dangerous, or do recurrent deficits reflect reversible timing mismatch rather than cumulative structural injury?

In retained muscle, microscopic damage around vessels could hide behind recovered resting flow. At matched muscular work, greater lasting defect growth and vessel collapse with larger local stress swings would distinguish this mechanism; normal structure with reversible deficits would reject it.

Explains the gap: Does apparent recovery conceal persistent microvascular reserve loss that makes repeat output gains dangerous, or do recurrent deficits reflect reversible timing mismatch rather than cumulative structural injury?

In recipients after replacement and matched controls, apparent loss of reserve reflects changing workloads and measurement conditions. Equivalent demand and independently calibrated perfusion measurements would remove the deficit; persistent deficits would reject the claim.

Explains the gap: Does apparent recovery conceal persistent microvascular reserve loss that makes repeat output gains dangerous, or do recurrent deficits reflect reversible timing mismatch rather than cumulative structural injury?

In retained muscle fibers, a reversible calcium-phosphate deposit could leave contraction impaired after low-demand performance recovers. Restoring calcium release and force by dissolving the deposit outside the body would distinguish this explanation from persistent vascular injury.

Explains the gap: Does apparent recovery conceal persistent microvascular reserve loss that makes repeat output gains dangerous, or do recurrent deficits reflect reversible timing mismatch rather than cumulative structural injury?

Retained muscle fibers may conceal lost energy reserve by recruiting unaffected segments and motor units. The hypothesis predicts that intolerance maps to mitochondrial genome deletions despite abundant oxygen and fuel; normal intrinsic respiration in affected regions argues against it.

Explains the gap: Does apparent recovery conceal persistent microvascular reserve loss that makes repeat output gains dangerous, or do recurrent deficits reflect reversible timing mismatch rather than cumulative structural injury?

In an aged-animal endocrine replacement model, learned sensory cues would suppress donor-specific secretion and trigger unnecessary replacements. Cue-specific suppression without cell loss, reversed by cue extinction, would distinguish this explanation.

Explains the gap: Can smaller, dispersed replacements require more cumulative tissue because interface exposure and compensatory workload shorten useful life faster than smaller procedures shorten recovery?

In engineered endocrine microtissues, independent controllers may spend more energy keeping secretion steady, shortening useful life. Shared control should reduce failures and renewals at matched mass, secretion, oxygen delivery and dispersion; testing would then move to aged animals.

Explains the gap: Can smaller, dispersed replacements require more cumulative tissue because interface exposure and compensatory workload shorten useful life faster than smaller procedures shorten recovery?

Small, dispersed tissue replacements appear to consume more tissue because of monitoring and accounting choices. The excess should disappear under a shared renewal rule and complete accounting; persistent biological loss would refute the claim.

Explains the gap: Can smaller, dispersed replacements require more cumulative tissue because interface exposure and compensatory workload shorten useful life faster than smaller procedures shorten recovery?

In progenitor-containing replacement units, rare durable founder lineages may be lost despite adequate initial output. Balancing validated founders at matched cell number, initial output, and geometry should prevent delayed unit extinction and reduce cumulative renewals.

Explains the gap: Can smaller, dispersed replacements require more cumulative tissue because interface exposure and compensatory workload shorten useful life faster than smaller procedures shorten recovery?

In models expressing human islet amyloid polypeptide (IAPP), persistent protein seeds would make later endocrine grafts fail sooner at previously affected sites. Removing seeds should reset time to failure; transferring cell-free seed-containing material should shorten it at an unused site.

Explains the gap: Can smaller, dispersed replacements require more cumulative tissue because interface exposure and compensatory workload shorten useful life faster than smaller procedures shorten recovery?

In aged murine grafts, the hypothesis makes senescent host fibroblasts essential for immune tolerance. Removing them after pathogen clearance and restored drainage should increase donor-reactive lymphocyte survival and cause delayed loss of replacement function; preserved tolerance would refute their necessity.

Explains the gap: Does suppressing interface senescence after infection prevent reimpairment, or remove the repair program needed to restore drainage and perfusion—and what intervention timing separates these outcomes?

In endothelial-stromal cultures and aged grafts, the hypothesis makes safe suppression depend on a stable pattern of vessel-lining cell identities. Localized repair signals should rescue early suppression better than uniform delivery, restoring identity patterns before drainage and blood flow improve.

Explains the gap: Does suppressing interface senescence after infection prevent reimpairment, or remove the repair program needed to restore drainage and perfusion—and what intervention timing separates these outcomes?

Early harm and late benefit reflect changing cell targets or off-target effects, rather than a repair-to-injury switch in senescent stromal cells. A timing reversal that persists under two independent, validated perturbations of these cells would falsify this hypothesis.

Explains the gap: Does suppressing interface senescence after infection prevent reimpairment, or remove the repair program needed to restore drainage and perfusion—and what intervention timing separates these outcomes?

In aged graft models, the hypothesis predicts that suppressing senescent-cell secretions harms tissue during bleeding but helps after excess clotting begins. Platelet imaging, bleeding measurements and selective rescue would test whether clotting drives this timing reversal.

Explains the gap: Does suppressing interface senescence after infection prevent reimpairment, or remove the repair program needed to restore drainage and perfusion—and what intervention timing separates these outcomes?

Secretions from senescent cells may shift lymphatic muscle from effective pulses to sustained activation. Changes within minutes to hours and rescue by adjusting neurokinin signaling would distinguish this pumping mechanism from loss of tissue repair.

Explains the gap: Does suppressing interface senescence after infection prevent reimpairment, or remove the repair program needed to restore drainage and perfusion—and what intervention timing separates these outcomes?

In lineage-barcoded liver–muscle systems, repeated equal-calorie meal shifts select expanding liver cell clones that delay glucose handling. Restoring original clone proportions at identical total cell number would restore timing; increasing exchange alone would not.

Explains the gap: Does host–replacement metabolic coordination obey an Adler phase-locking threshold, such that modest meal shifts cause persistent desynchronization despite adequate local clocks, and can increasing coupling restore function without additional tissue?

In a replacement liver compartment, misplaced glucose-producing and glucose-consuming cell territories would explain delayed metabolism. Changing the spatial WNT signal should move territory boundaries before restoring glucose production and uptake timing at unchanged tissue mass.

Explains the gap: Does host–replacement metabolic coordination obey an Adler phase-locking threshold, such that modest meal shifts cause persistent desynchronization despite adequate local clocks, and can increasing coupling restore function without additional tissue?

In linked microphysiological systems—small laboratory models of connected tissues—the apparent coordination failure would be a measurement artifact. Resampling and remixing would shift the apparent threshold; a persistent defect traced directly to a compartment would falsify the claim.

Explains the gap: Does host–replacement metabolic coordination obey an Adler phase-locking threshold, such that modest meal shifts cause persistent desynchronization despite adequate local clocks, and can increasing coupling restore function without additional tissue?

In replacement-derived muscle, impaired insulin passage across the blood-vessel lining delays the response to meals. Direct delivery into the space around muscle cells should promptly normalize glucose uptake and its lag while vascular insulin waveforms and tissue clock phases stay constant.

Explains the gap: Does host–replacement metabolic coordination obey an Adler phase-locking threshold, such that modest meal shifts cause persistent desynchronization despite adequate local clocks, and can increasing coupling restore function without additional tissue?

In human liver constructs, persistent enzyme assemblies could explain delayed metabolic output after meal shifts. A selective change that prevents assembly while preserving baseline enzyme activity would eliminate the lag; increased exchange between compartments would not.

Explains the gap: Does host–replacement metabolic coordination obey an Adler phase-locking threshold, such that modest meal shifts cause persistent desynchronization despite adequate local clocks, and can increasing coupling restore function without additional tissue?

In aged muscle-replacement animals, sensory stimulation timed to attempted movements could restore voluntary force without graft contraction during training. Lasting recovery that extends to an untrained mobility task would distinguish learned suppression from loss of usable tissue.

Explains the gap: When replacement tissue remains viable after illness, can restoring neural recruitment and physiological loading recover lost output without renewal, disproving the assumption that declining function means insufficient surviving tissue?

The hypothesis says post-illness replacement muscle loses endurance as defective mitochondrial genomes expand within surviving fibers. Reducing their share should restore endurance without changing muscle mass or nerve recruitment; neural activation alone should not.

Explains the gap: When replacement tissue remains viable after illness, can restoring neural recruitment and physiological loading recover lost output without renewal, disproving the assumption that declining function means insufficient surviving tissue?

In animal muscle grafts, apparent recovery reflects changes elsewhere in limb performance. Randomized graft-specific silencing, donor-selective activation, and antagonist electromyography estimate the graft's contribution to torque; a reproducible decline and recovery beyond the equivalence margin rejects the claim.

Explains the gap: When replacement tissue remains viable after illness, can restoring neural recruitment and physiological loading recover lost output without renewal, disproving the assumption that declining function means insufficient surviving tissue?

The hypothesis says replacement muscle remains capable of force after illness but cannot reliably carry electrical signals. Restoring membrane excitability would recover calcium signals and force within minutes; normal signal propagation during weakness or failed rescue after verified correction would reject it.

Explains the gap: When replacement tissue remains viable after illness, can restoring neural recruitment and physiological loading recover lost output without renewal, disproving the assumption that declining function means insufficient surviving tissue?

In surviving replacement muscle fibers, inhibited myosin motors limit force despite adequate activation and adenosine triphosphate (ATP). Abnormal motor kinetics under controlled conditions, and restored force after verified motor-state correction, would distinguish this mechanism from its rivals.

Explains the gap: When replacement tissue remains viable after illness, can restoring neural recruitment and physiological loading recover lost output without renewal, disproving the assumption that declining function means insufficient surviving tissue?

In partial liver replacement, donor cells may eliminate useful native cells before maturing. The decisive observation would be that selectively reducing this competition lowers engraftment yet preserves combined organ function and lengthens the interval between renewals.

Explains the gap: Can staged boundary conditioning worsen durable function despite better engraftment because delayed handoff exhausts native reserve, and would matched replacement without conditioning preserve more function through repeated ordinary stress?

Retained renal tubular cells may enter a self-maintaining failed-repair state during the conditioning-to-handoff interval. Different injury and recovery thresholds, plus lasting recovery after a brief regulatory reset, would distinguish this claim from a smoothly reversible response.

Explains the gap: Can staged boundary conditioning worsen durable function despite better engraftment because delayed handoff exhausts native reserve, and would matched replacement without conditioning preserve more function through repeated ordinary stress?

The hypothesis says staged conditioning causes no persistent functional loss: unequal graft maturity and early renewal decisions create the appearance of harm. It predicts that differences disappear after a common maturation window and blinded review eliminates excess repeat procedures.

Explains the gap: Can staged boundary conditioning worsen durable function despite better engraftment because delayed handoff exhausts native reserve, and would matched replacement without conditioning preserve more function through repeated ordinary stress?

In animal models, delayed handoff is proposed to teach persistent movement suppression after graft and kidney recovery. Greater activity recovery with success-linked training than with matched training would distinguish learned nonuse from lost physiological capacity.

Explains the gap: Can staged boundary conditioning worsen durable function despite better engraftment because delayed handoff exhausts native reserve, and would matched replacement without conditioning preserve more function through repeated ordinary stress?

In amyloid-characterized aged rodent hepatic replacement models, conditioning may improve initial engraftment but spread harmful protein shapes. Transfer of the effect by interface eluate, and its loss after seed depletion despite identical handoff delays, would distinguish this mechanism.

Explains the gap: Can staged boundary conditioning worsen durable function despite better engraftment because delayed handoff exhausts native reserve, and would matched replacement without conditioning preserve more function through repeated ordinary stress?

In initially nonmalignant replacement tissue, antigen-specific tolerance is proposed to cause more late malignant escape than immune cloaking. The deciding observation is fewer abnormal cells initially but more invasive donor-derived lesions later, counted per original recipient under matched conditions.

Explains the gap: Does durable graft acceptance create a compartment where infection or abnormal clones escape surveillance, and can antigen-specific tolerance separate these outcomes better than immune cloaking at matched functional engraftment?

In accepted grafts, repeated target encounters may exhaust local immune cells’ killing supplies despite preserved recognition. Slower killing with depleted supplies, followed by recovery after rest or replacement with rested cells, would distinguish depletion from inherited target escape.

Explains the gap: Does durable graft acceptance create a compartment where infection or abnormal clones escape surveillance, and can antigen-specific tolerance separate these outcomes better than immune cloaking at matched functional engraftment?

In donor-cell grafts, apparent links between graft acceptance, persistent infection and abnormal-cell escape arise from who is included and how burdens are counted. The link disappears with assignment-based analysis; a reproducible local rescue with unchanged counting bases and inclusion rejects the claim.

Explains the gap: Does durable graft acceptance create a compartment where infection or abnormal clones escape surveillance, and can antigen-specific tolerance separate these outcomes better than immune cloaking at matched functional engraftment?

The hypothesis attributes poor infection control and abnormal-cell killing in grafts to intracellular immunosuppressant exposure. Restored killing after drug washout, followed by renewed impairment on re-exposure, would distinguish it; persistence in fully drug-free grafts would reject it as dominant.

Explains the gap: Does durable graft acceptance create a compartment where infection or abnormal clones escape surveillance, and can antigen-specific tolerance separate these outcomes better than immune cloaking at matched functional engraftment?

In epithelial replacements, infection can persist because neutralizing defenses do not reach the lumen despite effective surveillance on the tissue side. Direct luminal delivery should accelerate clearance without changing abnormal-clone killing; persistence despite adequate delivery would refute the explanation.

Explains the gap: Does durable graft acceptance create a compartment where infection or abnormal clones escape surveillance, and can antigen-specific tolerance separate these outcomes better than immune cloaking at matched functional engraftment?

In an aged replacement-recovery animal model, early protected activity may overload kidney energy processing despite adequate oxygen and maintained energy stores. Preventing injury by selectively suppressing oxidant production, without improving oxygen delivery or reducing graft loading, would support this claim.

Explains the gap: Can earlier protected mobilization improve graft mechanics yet worsen cerebral or renal recovery compared with reserve-gated mobilization, even when both schedules satisfy local healing limits?

In postoperative patients, movement may trigger clotting that persists after activity stops. Serial plasma assays and paired tests outside the body would distinguish this claim by showing different inputs needed to start and sustain clotting, and whether selective clotting inhibition ends persistence.

Explains the gap: Can earlier protected mobilization improve graft mechanics yet worsen cerebral or renal recovery compared with reserve-gated mobilization, even when both schedules satisfy local healing limits?

In recipients of tissue grafts, earlier protected movement improves graft mechanics without causing lasting brain or kidney dysfunction. The apparent harm disappears when assessment timing is matched; reproducible persistent injury or dependence would refute the claim.

Explains the gap: Can earlier protected mobilization improve graft mechanics yet worsen cerebral or renal recovery compared with reserve-gated mobilization, even when both schedules satisfy local healing limits?

Activity after tissue replacement may improve graft mechanics while muscle-derived extracellular vesicles prolong kidney injury. The deciding observation is whether removing plasma vesicles eliminates transferable toxicity in pre-injured renal-tubule cultures and adding them back restores it.

Explains the gap: Can earlier protected mobilization improve graft mechanics yet worsen cerebral or renal recovery compared with reserve-gated mobilization, even when both schedules satisfy local healing limits?

In susceptible recipients already prescribed drugs delivered through skin, early mobilization may trigger drug peaks that impair brain or kidney recovery. Eliminating those peaks while preserving the drug's intended effect would retain the mechanical benefit without excess remote harm.

Explains the gap: Can earlier protected mobilization improve graft mechanics yet worsen cerebral or renal recovery compared with reserve-gated mobilization, even when both schedules satisfy local healing limits?

In healed, compression-loaded replacement interfaces, collagen connectivity is proposed to preserve fluid exchange even as stiffness increases. Matched collagen constructs test this claim: immediate improvement in hydraulic conductance after verified bridge severing would falsify it.

Explains the gap: At equal scar mass, does crossing a collagen-network percolation threshold cause interface restriction, and can selectively breaking network connectivity restore exchange without reopening the wound?

In living constructs initially matched for scar mass and network structure, stromal cells may sustain restriction through competition for attachment sites. Lasting effects of arrival order and takeover after selective depletion would distinguish this mechanism from restriction set by connectivity alone.

Explains the gap: At equal scar mass, does crossing a collagen-network percolation threshold cause interface restriction, and can selectively breaking network connectivity restore exchange without reopening the wound?

In the tested interfaces, restriction reflects local scar geometry and loading rather than a sharp collagen-connectivity threshold. Imaging-dependent threshold estimates and smooth functional relationships would support this claim; a reproducible intervention-linked breakpoint would falsify it.

Explains the gap: At equal scar mass, does crossing a collagen-network percolation threshold cause interface restriction, and can selectively breaking network connectivity restore exchange without reopening the wound?

The hypothesis locates the persistent defect in collecting lymphatic vessels. Restoring their pumping would improve fluid clearance before collagen connections change; normal pumping with persistently low passive fluid conductance would falsify it.

Explains the gap: At equal scar mass, does crossing a collagen-network percolation threshold cause interface restriction, and can selectively breaking network connectivity restore exchange without reopening the wound?

In microfluidic interfaces, scar binding sites would retain charged solutes and native proteins while sparing neutral tracers and bulk water. Restoring exchange by modifying those sites, with collagen connectivity and wound strength unchanged, would distinguish chemical trapping from a structural barrier.

Explains the gap: At equal scar mass, does crossing a collagen-network percolation threshold cause interface restriction, and can selectively breaking network connectivity restore exchange without reopening the wound?

In aged animal graft models, keeping donor and host tissue clocks apart would protect immunologically mismatched tissue without more immune suppression. Alignment causing immune injury and slower recovery under matched conditions, with an offset preventing both, would distinguish this explanation.

Explains the gap: Does aligning meals with sleep worsen recovery when replacement tissue and host liver remain out of phase, despite improving average glucose, and does tissue-phase alignment reverse that harm?

In aged animals, the hypothesis predicts that replacement muscle takes glucose needed by retained tissues when liver supply is low. Tracer measurements and timed redistribution of the same daily carbohydrate supply test whether recovery improves without correcting tissue timing.

Explains the gap: Does aligning meals with sleep worsen recovery when replacement tissue and host liver remain out of phase, despite improving average glucose, and does tissue-phase alignment reverse that harm?

During replacement recovery, meals aligned with sleep could improve average glucose while reducing absorbed protein available for repair. Matching systemic amino-acid exposure would remove the recovery difference even if replacement tissue and liver remain out of phase.

Explains the gap: Does aligning meals with sleep worsen recovery when replacement tissue and host liver remain out of phase, despite improving average glucose, and does tissue-phase alignment reverse that harm?

In aged animal models with defined microbial communities, meal timing could delay recovery despite better average glucose by changing microbial metabolites and drug toxicity. Removing the implicated microbial activity should prevent injury; metabolite add-back should restore it.

Explains the gap: Does aligning meals with sleep worsen recovery when replacement tissue and host liver remain out of phase, despite improving average glucose, and does tissue-phase alignment reverse that harm?

In tissue-replacement studies, apparent meal-timing harm reflects when testing occurs relative to biological rhythms and feeding. The claim predicts no worsening of performance across the day or sustained recovery; a persistent functional deficit with a mechanism-specific rescue would refute it.

Explains the gap: Does aligning meals with sleep worsen recovery when replacement tissue and host liver remain out of phase, despite improving average glucose, and does tissue-phase alignment reverse that harm?

In aged mice, the hypothesis predicts that inhibiting neurons linked to the first replacement abolishes excess injury and lasting disability after an identical repeat procedure. Persistence despite verified inhibition would refute neural memory as the dominant mechanism.

Explains the gap: Does apparent recovery between replacements erase treatment debt, or do clinically recovered recipients retain sequence-dependent damage that makes the next identical procedure disproportionately disabling?

In lineage-traced epithelial replacements and recovered host-derived organoids, prior injury could leave cells locked in repair despite recovered function. Different switching thresholds and lasting recovery after a maturation pulse would distinguish this mechanism from a reversible response.

Explains the gap: Does apparent recovery between replacements erase treatment debt, or do clinically recovered recipients retain sequence-dependent damage that makes the next identical procedure disproportionately disabling?

In retained skeletal muscle fibers, persistent protein assemblies could hide damage after strength recovers. Impaired protein production after a second stress—and reversal after selective assembly dissolution—would distinguish this proposed memory mechanism.

Explains the gap: Does apparent recovery between replacements erase treatment debt, or do clinically recovered recipients retain sequence-dependent damage that makes the next identical procedure disproportionately disabling?

In clinically recovered animals, repeated procedures may leave individual muscle cells with harmful mitochondrial DNA (deoxyribonucleic acid) mixtures despite restored average function. Failure under matched stress, and its removal by mutation-specific depletion, would test this claim.

Explains the gap: Does apparent recovery between replacements erase treatment debt, or do clinically recovered recipients retain sequence-dependent damage that makes the next identical procedure disproportionately disabling?

Randomized animal schedules followed from the first attempt test whether treatment history adds clinically meaningful harm after genuine recovery. Accounting for age, actual procedural injury, repeated recovery measurements, death and non-recovery should remove the apparent extra harm.

Explains the gap: Does apparent recovery between replacements erase treatment debt, or do clinically recovered recipients retain sequence-dependent damage that makes the next identical procedure disproportionately disabling?